MAPT and Alzheimer disease: In AD, MMP2 was shown to degrade Aβ via cleaving soluble Aβ peptides, was upregulated around astrocytes in AD brain [60], and was shown to accumulate near NFTs to eliminate the toxic form of tau [61].